US Patent Issued to Active Genomes Expressed Diagnostics on Sept. 30 for "Methods for detecting and treating a tumorigenic phenotype of the liver" (District Of Columbia Inventor)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,684, issued on Sept. 30, was assigned to Active Genomes Expressed Diagnostics Corp (Bethesda, Md.).

"Methods for detecting and treating a tumorigenic phenotype of the liver" was invented by Rachel Zayas (Washington).

According to the abstract* released by the U.S. Patent & Trademark Office: "In an aspect, a method comprises (a) isolating cell-free DNA molecules obtained or derived from a blood sample of a subject; (b) subjecting the cfDNA molecules to TET-associated sequencing comprising: (i) using a TET enzyme to oxidize 5-mC residues and 5-hmC residues of the cfDNA molecules, (ii) sequencing the TET-converted cfDNA molecules to produce a set of cfDNA methylation sequencing rea...